美國印太司令部：對油輪“達維娜”號的登船檢查已於昨夜完成。

UBS says Hong Kong equity market has been highly active with a structural shift toward hard-tech and new-economy issuers; sci‑tech firms accounted for 63% of HK IPO volume YTD versus 16% a year earlier. UBS investment banking co-head says HK equity financing reached about $43 bln in the first five months of 2026, up from $28 bln a year earlier. UBS Research forecasts full-year Hong Kong IPO proceeds of $45–50 bln and remains confident the HSI will break 30,000 this year. Looking to H2, UBS expects China market momentum to be driven by substantive corporate profit growth and prefers two asset types: large-cap tech leaders benefitting from global AI deployment and technology self-sufficiency, and small/mid-cap firms with structural overseas-expansion capabilities.

China private securities product filings rose 49.15% YoY in the first five months to 6,530 from 4,378. Equity-strategy products drove the increase, with 4,222 filings (+51.11% YoY) accounting for roughly 65% of total filings, supported by firmer A-share trading activity. Index-enhanced strategies were the fastest-growing subset: 1,603 filings (+73.30% YoY), about 38.0% of equity-strategy filings. Filings remain concentrated among large private managers; firms with assets under management above 10 billion yuan form the primary first-tier of private securities product registrants.